Zobrazeno 1 - 10
of 37
pro vyhledávání: '"Paola, A. Barroso"'
Autor:
María Laura Guzman, María Florencia Peralta, Marcelo Quipildor, Francesca Papera, Elvia Mejía, Juan José Lauthier, Manuela Bono, Paola Andrea Barroso, María Eugenia Olivera, Dolores Catalina Carrer
Publikováno v:
Precision Nanomedicine, Vol 6, Iss 4 (2023)
A male rural worker with cutaneous leishmaniasis (CL) was initially treated with repeated cycles of Meglumine Antimoniate (Glucantime®) and two cycles of Amphotericin B deoxycholate during a three-year period. However, the patient remained with two
Externí odkaz:
https://doaj.org/article/9ecd0a5af2064366979c5b6fc8c1bf1d
Autor:
María Fernanda García-Bustos, Agustín Moya Álvarez, Cecilia Pérez Brandan, Cecilia Parodi, Andrea Mabel Sosa, Valeria Carolina Buttazzoni Zuñiga, Oscar Marcelo Pastrana, Paula Manghera, Pablo Alejandro Peñalva, Jorge Diego Marco, Paola Andrea Barroso
Publikováno v:
Frontiers in Cellular and Infection Microbiology, Vol 11 (2021)
Antimonials continue to be considered the first-line treatment for leishmaniases, but its use entails a wide range of side effects and serious reactions. The search of new drugs requires the development of methods more sensitive and faster than the c
Externí odkaz:
https://doaj.org/article/64ed423ab05847a0a0647199878901b8
Autor:
Ma. Florencia Peralta, Ma. Laura Guzman, Ma. Estefanía Bracamonte, J. Diego Marco, Ma. Eugenia Olivera, Dolores C. Carrer, Paola A. Barroso
Publikováno v:
Heliyon, Vol 7, Iss 5, Pp e07136- (2021)
An efficacious topical treatment for cutaneous leishmaniasis (CL) is highly desirable but still an ongoing challenge. Systemic risedronate (Ris) has been reported to have anti-leishmanial properties and Eudragit EPO (EuE) has shown in vitro activity
Externí odkaz:
https://doaj.org/article/18057b7718e84694a725466e5b5db715
Autor:
María E Bracamonte, Agustín Moya Álvarez, Andrea M Sosa, Carlos L Hoyos, Juan J Lauthier, Silvana P Cajal, Marisa Juarez, Renato E Uncos, Fernando J Sánchez-Valdéz, Leonardo Acuña, Patricio Diosque, Miguel A Basombrío, Julio R Nasser, Yoshihisa Hashiguchi, Masataka Korenaga, Paola A Barroso, Jorge D Marco
Publikováno v:
PLoS ONE, Vol 15, Iss 5, p e0232829 (2020)
The diagnosis of American tegumentary leishmaniasis (ATL) still requires the design of more effective tools. Leishmania (Viannia) braziliensis is the causal agent of the 90% of Argentinean ATL cases. Considering the current knowledge, an ELISA based
Externí odkaz:
https://doaj.org/article/f8d24d2a2bc94f8e8f3bfa09f22c5461
Autor:
Andrea M. Sosa, Agustín Moya Álvarez, Estefanía Bracamonte, Masataka Korenaga, Jorge D. Marco, Paola A. Barroso
Publikováno v:
Molecules, Vol 25, Iss 7, p 1741 (2020)
The treatment of leishmaniasis includes pentavalent antimony drugs but, because of the side effects, toxicity and cases of treatment failure or resistance, the search of new antileishmanial compounds are necessary. The aims of this study were to eval
Externí odkaz:
https://doaj.org/article/5be152177c99481d8b79efbd1a3926fd
Autor:
Dolores C. Carrer, Ma. Laura Guzman, Ma. Eugenia Olivera, Ma. Florencia Peralta, J. Diego Marco, Paola Andrea Barroso, Ma. Estefanía Bracamonte
Publikováno v:
Heliyon
Heliyon, Vol 7, Iss 5, Pp e07136-(2021)
CONICET Digital (CONICET)
Consejo Nacional de Investigaciones Científicas y Técnicas
instacron:CONICET
Heliyon, Vol 7, Iss 5, Pp e07136-(2021)
CONICET Digital (CONICET)
Consejo Nacional de Investigaciones Científicas y Técnicas
instacron:CONICET
An efficacious topical treatment for cutaneous leishmaniasis (CL) is highly desirable but still an ongoing challenge. Systemic risedronate (Ris) has been reported to have anti-leishmanial properties and Eudragit EPO (EuE) has shown in vitro activity
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9aa942a8c7a2da37318d8e635ca98c21
http://europepmc.org/articles/PMC8173260
http://europepmc.org/articles/PMC8173260
Autor:
Dolores C. Carrer, J. Diego Marco, Nadina A Usseglio, Ma. Eugenia Olivera, Ma. Estefanía Bracamonte, Ma. Laura Guzman, Ma Florencia Peralta, Paola Andrea Barroso
Publikováno v:
Drug delivery and translational research. 12(1)
Cutaneous leishmaniasis (CL) is a neglected tropical disease endemic in ~ 90 countries, with an increasing incidence. Presently available pharmacotherapy implies the systemic administration of moderately/very toxic drugs. Miltefosine (Milt) is the on
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c54d7bac05db6c2124f5c3de5fd17f0c
https://pubmed.ncbi.nlm.nih.gov/33502733
https://pubmed.ncbi.nlm.nih.gov/33502733
Autor:
Maria Laura Guzman, Maria Estefania Bracamonte, Dolores C. Carrer, Jorge Diego Marco, Maria Florencia Peralta, María Eugenia Olivera, Paola Andrea Barroso
Publikováno v:
CONICET Digital (CONICET)
Consejo Nacional de Investigaciones Científicas y Técnicas
instacron:CONICET
Ciências da Saúde: desafios, perspectivas e possibilidades-Volume 1 ISBN: 9786589826637
Ciências da Saúde: desafios, perspectivas e possibilidades-Volume 1
Consejo Nacional de Investigaciones Científicas y Técnicas
instacron:CONICET
Ciências da Saúde: desafios, perspectivas e possibilidades-Volume 1 ISBN: 9786589826637
Ciências da Saúde: desafios, perspectivas e possibilidades-Volume 1
Cutaneous leishmaniasis (CL) is a neglected tropical disease endemic in ~90 countries, with an increasing incidence. Presently available pharmacotherapy implies the systemic administration of moderately/very toxic drugs. Miltefosine (Milt) is the onl
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1f169ca31f544a74312f4bf6ecc9c4ff
https://www.editoracientifica.org/books/isbn/978-65-89826-63-7
https://www.editoracientifica.org/books/isbn/978-65-89826-63-7
Autor:
Agustín Moya Álvarez, Jorge Diego Marco, Juan José Lauthier, Marisa Juarez, Renato E. Uncos, Yoshihisa Hashiguchi, Fernando J. Sánchez-Valdéz, Miguel A. Basombrío, Maria Estefania Bracamonte, Leonardo Acuña, Paola Andrea Barroso, Patricio Diosque, Andrea M. Sosa, Julio R. Nasser, Carlos Lorenzo Hoyos, Masataka Korenaga, Silvana P. Cajal
Publikováno v:
PLoS ONE
PLoS ONE, Vol 15, Iss 5, p e0232829 (2020)
CONICET Digital (CONICET)
Consejo Nacional de Investigaciones Científicas y Técnicas
instacron:CONICET
PLoS ONE, Vol 15, Iss 5, p e0232829 (2020)
CONICET Digital (CONICET)
Consejo Nacional de Investigaciones Científicas y Técnicas
instacron:CONICET
The diagnosis of American tegumentary leishmaniasis (ATL) still requires the design of more effective tools. Leishmania (Viannia) braziliensis is the causal agent of the 90% of Argentinean ATL cases. Considering the current knowledge, an ELISA based
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8eca5ba4a3aaa041d40667fed70d9c70
http://europepmc.org/articles/PMC7205302
http://europepmc.org/articles/PMC7205302
Autor:
Jorge Diego Marco, Estefanía Bracamonte, Juan José Lauthier, Yoshihisa Hashiguchi, Alejandro Uncos, Paola Andrea Barroso, Pamela Cajal, Carlos Lorenzo Hoyos, Masataka Korenaga, Marcelo Quipildor
Publikováno v:
The Journal of Dermatology. 46
This paper describes a rare case of leishmaniasis with simultaneous presentation of cutaneous and mucosal lesions in endemic areas for leishmaniasis. Usually, such a case does not occur simultaneously in cutaneous (CL) or mucocutaneous leishmaniasis.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d0dc1cbaa13fedb727bcb4bc2667b73e
https://doi.org/10.1111/1346-8138.14866
https://doi.org/10.1111/1346-8138.14866